Adults newly diagnosed with narcolepsy type 1 rack up healthcare costs 5.5 times higher than people without the condition, a ...

Federal HIV guidelines add Bixlenvo as a switch option, back statins for adults 40 to 75 and urge clinicians to challenge payer barriers to antiretroviral therapy (ART).

Sempre Health works with health plans, pharmacy benefit managers (PBMs), drugmakers and patients to lower out-of-pocket costs. Mathur is co-presenting “The Last Mile at Point-of ...

Adam Colborn, vice president of government affairs at AMCP, said the Consolidated Appropriations Act of 2026 (CAA), signed ...

Calling intismeran a cancer vaccine is catchy and makes some sense, but it lacks precision. Moderna and Merck are describing ...

Christine Johnston says biosimilar interchangeability bills, plus 2026 PBM reforms, would force PBMs to justify preferring higher-cost brands. Proposed legislation that would make approved biosimilars ...

Early-stage lung cancer patients on Tagrisso are living past 8 years ...

A Cencora analysis of 32 pre-approval products found more than 60% of payer engagement with PIE resources came more than 90 ...

Ty Gluckman, M.D., says the 2026 dyslipidemia guideline brings back risk-based LDL goals, and clinical inertia, not access, ...

Ty Gluckman, M.D., says undertesting and undertreatment are the biggest gaps in lipid care and calls on leaders to invest in ...

Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacy should be treated as a clinical service line, not just a 340B ...

The chief pharmacy officer role has changed significantly over the past five years, shifting away from running operations and ...